Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist

被引:37
作者
Baraboi, Elena-Dana
Smith, Pauline [2 ]
Ferguson, Alastair V. [2 ]
Richard, Denis [1 ]
机构
[1] Inst Univ Cardiol & Pneumol Quebec, Direct Rech, Ste Foy, PQ G1V 4G5, Canada
[2] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada
基金
加拿大健康研究院;
关键词
food intake; energy expenditure; hypothalamic-pituitary-adrenal axis; glucose metabolism; c-fos; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; FOOD-INTAKE; MESSENGER-RNAS; C-FOS; PARABRACHIAL NUCLEUS; SOLITARY TRACT; BED NUCLEUS; RAT; ENERGY;
D O I
10.1152/ajpregu.00326.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Baraboi ED, Smith P, Ferguson AV, Richard D. Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist. Am J Physiol Regul Integr Comp Physiol 298: R1098-R1110, 2010. First published January 27, 2010; doi: 10.1152/ajpregu.00326.2009.-The mechanism and route whereby glucagon-like peptide 1 (GLP-1) receptor agonists, such as GLP-1 and exendin-4 (Ex-4), access the central nervous system (CNS) to exert their metabolic effects have yet to be clarified. The primary objective of the present study was to investigate the potential role of two circumventricular organs (CVOs), the area postrema (AP) and the subfornical organ (SFO), in mediating the metabolic and CNS-stimulating effects of Ex-4. We demonstrated that electrolytic ablation of the AP, SFO, or AP + SFO does not acutely prevent the anorectic effects of Ex-4. AP + SFO lesion chronically decreased food intake and body weight and also modulated the effect of Ex-4 on the neuronal activation of brain structures involved in the hypothalamic-pituitary-adrenal axis and glucose metabolism. The results of the study also showed that CVO lesions blunted Ex-4-induced expression of c-fos mRNA (a widely used neuronal activity marker) in 1) limbic structures (bed nucleus of the stria terminalis and central amygdala), 2) hypothalamus (paraventricular hypothalamic nucleus, supraoptic nucleus, and arcuate nucleus), and 3) hindbrain (lateral and lateral-external parabrachial nucleus, medial nucleus of the solitary tract, and ventrolateral medulla). In conclusion, although the present results do not support a role for the CVOs in the anorectic effect induced by a single injection of Ex-4, they suggest that the CVOs play important roles in mediating the actions of Ex-4 in the activation of CNS structures involved in homeostatic control.
引用
收藏
页码:R1098 / R1110
页数:13
相关论文
共 67 条
[1]   The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway [J].
Abbott, CR ;
Monteiro, M ;
Small, CJ ;
Sajedi, A ;
Smith, KL ;
Parkinson, JRC ;
Ghatei, MA ;
Bloom, SR .
BRAIN RESEARCH, 2005, 1044 (01) :127-131
[2]  
Al-Barazanji KA, 2000, OBES RES, V8, P317, DOI 10.1038/oby.2000.38
[3]   Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides [J].
Aziz, A ;
Anderson, GH ;
Giacca, A ;
Cho, F .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (03) :R688-R694
[4]   An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose Homeostasis [J].
Baggio, Laurie L. ;
Huang, Qingling ;
Cao, Xiemin ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2008, 134 (04) :1137-1147
[5]   A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis [J].
Baggio, LL ;
Huang, QL ;
Brown, TJ ;
Drucker, DJ .
DIABETES, 2004, 53 (09) :2492-2500
[6]   Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure [J].
Baggio, LL ;
Huang, QL ;
Brown, TJ ;
Drucker, DJ .
GASTROENTEROLOGY, 2004, 127 (02) :546-558
[7]   Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats [J].
Barrera, Jason G. ;
D'Alessio, David A. ;
Drucker, Daniel J. ;
Woods, Stephen C. ;
Seeley, Randy J. .
DIABETES, 2009, 58 (12) :2820-2827
[8]   Neuropeptide Y in normal eating and in genetic and dietary-induced obesity [J].
Beck, B. .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1471) :1159-1185
[9]   Multiple neural systems controlling food intake and body weight [J].
Berthoud, HR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2002, 26 (04) :393-428
[10]  
CARLSON ON, 1985, B ALLOY PHASE DIAGRA, V6, P2